Hendrickson & Long PLLC

West Virginia

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases2

Challenger50%

Patent Owner50%

NPE50%

hendrickson-long

handl.com

Practice Areas

Biotech

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
12/12/24	Regeneron Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 1:22-CV-00061 ( N.D. WV )	ORDER. For good cause, the following motions to withdraw are GRANTED: ECF Nos. [426] , [427] , [438] . The Clerk SHALL terminate Jennifer Brooks Crozier, Rocco Recce, Anish R. Desai, Kathryn Leicht, Kellie Van Beck, Matthew D. Sieger, Natalie C. Kennedy, Tom Yu, and Zhen Lin as counsel of record in this matter. Additionally, for good cause, the following motions to seal are GRANTED: ECF Nos. [429] , [431] . Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 12/12/2024) ORDER. For good cause, the following motions to withdraw are GRANTED: ECF Nos. [426] , [427] , [438] . The Clerk SHALL terminate Jennifer Brooks Crozier, Rocco Recce, Anish R. Desai, Kathryn Leicht, Kellie Van Beck, Matthew D. Sieger, Natalie C. Kennedy, Tom Yu, and Zhen Lin as counsel of record in this matter. Additionally, for good cause, the following motions to seal are GRANTED: ECF Nos. [429] , [431] . Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 12/12/2024)
12/12/24	Regeneron Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 1:22-CV-00061 ( N.D. WV )	MOTION to Withdraw as Attorney ANISH R. DESAI, KATHRYN LEICHT, KELLIE VAN BECK, MATTHEW D. SEIGER, NATALIE C. KENNEDY, TOM YU, AND ZHEN LIN'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/12/2024)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	NOTICE of Appearance by Gordon H. Copland on behalf of Kindeva Drug Delivery L.P., Mylan Pharmaceuticals Inc. (Copland, Gordon) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	REPORT to USPTO on the filing or determination of an action regarding re 1 Complaint. (kam) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	Report on the Filing or Determination of an Action Regarding a Patent or Trademark Other Document filed by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Law, Sandra) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA) Other Document filed by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Law, Sandra) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	Corporate Disclosure Statement by Astrazeneca Pharmaceuticals LP identifying Corporate Parent AstraZeneca PLC for Astrazeneca Pharmaceuticals LP.. (Law, Sandra) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	Corporate Disclosure Statement by AstraZeneca AB identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB.. (Law, Sandra) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	Exhibit B Other Document re 1 Complaint filed by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Law, Sandra) (Entered: 04/26/2022)
04/26/22	Astrazeneca Ab v. Mylan Pharma Inc 1:22-CV-00035 ( N.D. WV )	COMPLAINT against Kindeva Drug Delivery L.P., Mylan Pharmaceuticals Inc. (Filing Fee $402. Receipt #AWVNDC-3469018), filed by Astrazeneca Pharmaceuticals LP, AstraZeneca AB. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A) (kam) (Entered: 04/26/2022)